Optimal effector functions in human natural killer cells rely upon autocrine bone morphogenetic protein signaling
dc.contributor.author | Robson, Neil C. | |
dc.contributor.author | Hidalgo, Laura | |
dc.contributor.author | McAlpine, Tristan | |
dc.contributor.author | Wei, Heng | |
dc.contributor.author | Martínez, Víctor G. | |
dc.contributor.author | Entrena Martínez, Ana | |
dc.contributor.author | Melen, Gustavo J. | |
dc.contributor.author | MacDonald, Andrew S. | |
dc.contributor.author | Phythian-Adams, Alexander | |
dc.contributor.author | Sacedón Ayuso, Rosa | |
dc.contributor.author | Maraskovsky, Eugene | |
dc.contributor.author | Cebon, Jonathan | |
dc.contributor.author | Ramírez, Manuel | |
dc.contributor.author | Vicente, Ángeles | |
dc.contributor.author | Varas, Alberto | |
dc.date.accessioned | 2023-06-17T12:27:48Z | |
dc.date.available | 2023-06-17T12:27:48Z | |
dc.date.issued | 2018-09 | |
dc.description.abstract | Natural killer (NK) cells are critical for innate tumor immunity due to their specialized ability to recognize and kill neoplastically transformed cells. However, NK cells require a specific set of cytokine-mediated signals to achieve optimal effector function. Th1-associated cytokines promote effector functions that are inhibited by the prototypic Th2 cytokine IL4 and the TGFb superfamily members TGFb1 and activin-A. Interestingly, the largest subgroup of the TGFb superfamily are the bone morphogenetic proteins (BMP), but the effects of BMP signaling on NK cell effector functions have not been evaluated. Here, we demonstrate that blood-circulating NK cells express type I and II BMP receptors, BMP-2 and BMP-6 ligands, and phosphorylated isoforms of Smad-1/-5/-8, which mediate BMP family member signaling. In opposition to the inhibitory effects of TGFb1 or activin-A, autocrine BMP signaling was supportive to NK cell function. Mechanistic investigations in cytokine and TLR-L–activated NK cells revealed that BMP signaling optimized IFNg and global cytokine and chemokine production, phenotypic activation and proliferation, and autologous dendritic cell activation and target cytotoxicity. Collectively, our findings identify a novel auto-activatory pathway that is essential for optimal NK cell effector function, one that might be therapeutically manipulated to help eradicate tumors. | en |
dc.description.department | Depto. de Biología Celular | |
dc.description.faculty | Fac. de Ciencias Biológicas | |
dc.description.refereed | TRUE | |
dc.description.sponsorship | Ministerio de Economía, Comercio y Empresa (España) | |
dc.description.sponsorship | Ministerio de Educación, Formación Profesional y Deportes (España) | |
dc.description.sponsorship | Comunidad de Madrid | |
dc.description.sponsorship | Instituto de Salud Carlos III | |
dc.description.sponsorship | Australian National Health and Medical Research Council (NHMRC) | |
dc.description.sponsorship | Ludwig Institute for Cancer Research | |
dc.description.sponsorship | University of Glasgow | |
dc.description.status | pub | |
dc.eprint.id | https://eprints.ucm.es/id/eprint/47722 | |
dc.identifier.citation | Robson, N. C., Hidalgo, L., McAlpine, T. et al. «Optimal Effector Functions in Human Natural Killer Cells Rely upon Autocrine Bone Morphogenetic Protein Signaling». Cancer Research, vol. 74, n.o 18, septiembre de 2014, pp. 5019-31. Crossref, https://doi.org/10.1158/0008-5472.can-13-2845. | |
dc.identifier.doi | 10.1158/0008-5472.CAN-13-2845 | |
dc.identifier.essn | 1538-7445 | |
dc.identifier.issn | 0008-5472 | |
dc.identifier.officialurl | https//doi.org/10.1158/0008-5472.CAN-13-2845 | |
dc.identifier.relatedurl | http://cancerres.aacrjournals.org/content/74/18/5019 | |
dc.identifier.uri | https://hdl.handle.net/20.500.14352/12142 | |
dc.issue.number | 18 | |
dc.journal.title | Cancer research | |
dc.language.iso | eng | |
dc.page.final | 5031 | |
dc.page.initial | 5019 | |
dc.publisher | American Association for Cancer Research | |
dc.relation.projectID | SAF2012–33180 | |
dc.relation.projectID | CELLCAM (S2010/BMD-2420) | |
dc.relation.projectID | RD12/0019/0007 | |
dc.relation.projectID | (AP2009–4324 and AP2010–0795 | |
dc.relation.projectID | Industrial Fellowship Grant | |
dc.relation.projectID | (Wellcome Fellowship, Honorary Senior Research Fellow and Practitioner fellow) | |
dc.relation.projectID | Lord Kelvin Adam Smith Fellowship | |
dc.rights.accessRights | restricted access | |
dc.subject.cdu | 577.112 | |
dc.subject.cdu | 616-006.04 | |
dc.subject.keyword | Human killer cells | |
dc.subject.keyword | Bone morphogenetic | |
dc.subject.keyword | Protein Signaling | |
dc.subject.ucm | Oncología | |
dc.subject.ucm | Biología celular (Biología) | |
dc.subject.ucm | Bioquímica (Biología) | |
dc.subject.unesco | 3201.01 Oncología | |
dc.subject.unesco | 2407 Biología Celular | |
dc.subject.unesco | 2302 Bioquímica | |
dc.title | Optimal effector functions in human natural killer cells rely upon autocrine bone morphogenetic protein signaling | en |
dc.type | journal article | |
dc.volume.number | 74 | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 2106c210-7d55-4697-92b4-960b3af366c9 | |
relation.isAuthorOfPublication.latestForDiscovery | 2106c210-7d55-4697-92b4-960b3af366c9 |
Download
Original bundle
1 - 1 of 1
Loading...
- Name:
- Robson, N. et al. 2014. Optimal effector functions....pdf
- Size:
- 1.48 MB
- Format:
- Adobe Portable Document Format